For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a reality.

A living index of every problem, pattern, and system-design note I plant here — one big spreadsheet-style table, updated every time something new grows. Yes, it's going to get long. That's the point.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Anthropic co-founder Dario Amodei urges a deliberate slowdown in AI development, emphasizing ...

Carbon removal combined with emissions reduction is the only remaining pathway to avert catastrophic levels of warming, a new report warns. By Chico Harlan See more of our coverage in your search ...

Here's the deal ... while doing hard time for her role in the 2015 murder of her mother Dee Dee, Gypsy made a few calls to her family and her ex, Ryan Anderson... and in some of those conversations ...

ESPN host Pat McAfee greeted President Trump on the tarmac Tuesday before sitting with him during the 2026 Patriot Games. The association naturally angered the intolerant left, including one X user ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...